19-33090831-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018025.3(GPATCH1):āc.260C>Gā(p.Ser87Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018025.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPATCH1 | NM_018025.3 | c.260C>G | p.Ser87Cys | missense_variant | Exon 3 of 20 | ENST00000170564.7 | NP_060495.2 | |
GPATCH1 | XM_006723255.5 | c.260C>G | p.Ser87Cys | missense_variant | Exon 3 of 14 | XP_006723318.1 | ||
GPATCH1 | NR_135270.2 | n.273C>G | non_coding_transcript_exon_variant | Exon 3 of 21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPATCH1 | ENST00000170564.7 | c.260C>G | p.Ser87Cys | missense_variant | Exon 3 of 20 | 1 | NM_018025.3 | ENSP00000170564.1 | ||
GPATCH1 | ENST00000592165.1 | n.260C>G | non_coding_transcript_exon_variant | Exon 3 of 10 | 5 | ENSP00000467632.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461162Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 726958
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.